NCT01308996View on ClinicalTrials.gov

Clinical Study of INFUSE® Bone Graft Compared to Autogenous Bone Graft for Vertical Ridge Augmentation

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2017

Study Completion Date

September 30, 2017

Conditions
Alveolar Bone Loss in MandibleEdentulous Alveolar Ridge In Mandible
Interventions
DEVICE

INFUSE® Bone Graft

Implantation of INFUSE® Bone Graft \[recombinant human Bone Morphogenetic Protein-2 (rhBMP-2)\] and absorbable collagen sponge (ACS) carrier at 1.50 mg/cc with space maintenance device

PROCEDURE

Autogenous bone graft from tibia or iliac crest

Implantation of autogenous bone graft from iliac crest or tibia with titanium mesh space maintenance device

Sponsors
All Listed Sponsors
collaborator

Averion International Corporation

INDUSTRY

collaborator

Baim Institute for Clinical Research

OTHER

lead

Medtronic Spinal and Biologics

INDUSTRY